NorthWest Biotherapeutics Inc (NWBO)

[Barunuuk]

AVII - DID IMUC ENROLL RAPID PROGRESSORS???

I happen to think that IMUC didn't, and that the mOS ~20 months is not "DECREASED" because of the inclusion of Rapid progressors.

1), it states "ND-GBM" Newly diagnosed so not recurrent. And ....

2) this quote:

" the trial enrolled 278 patients at 25 centers throughout the U.S. and 124 patients were randomized to standard of care treatment plus ICT-107 or standard of care plus placebo (i.e., control). "

The fact that IMUC enrolled 278 patients, but less than half of them were randomized, tells me there was much more "Cherry-Picking" or "Screening" then one would think. Actually, that even strengthens the case that is the reason for such a high mOS of the control group.